Skip to main content

Generic Diagnosis of Amyloid: A Summary of Current Recommendations and the Editor’s Comments on Chapters 13–16

  • Chapter
Amyloid and Related Disorders

Part of the book series: Current Clinical Pathology ((CCPATH))

  • 1406 Accesses

Abstract

This chapter provides a brief summary of recommendations regarding current standards for the generic diagnosis of amyloidosis and outlines practical considerations and advice on the available options. Congo red stain continues to be the generally accepted standard in amyloid detection. It has been recently officially acknowledged that, besides apple-green birefringence, other anomalous colors, yellow or orange, are diagnostic of amyloid. However, successful application of the Congo red stain is dependent on many variables, including: preanalytic steps, technical issues associated with stain performance, and its interpretation, which also requires considerable experience on the part of the observer. All of these factors make the routine use of Congo red stain in general surgical pathology difficult and error-prone. In this chapter, technical issues associated with the Congo red stain and polarization, including the thickness of the sections, are summarized. Advantages and disadvantages of the use of other stains, in particular, Congo red fluorescence and Thioflavin stains, are also discussed. Finally, technical issues associated with the utilization of fat biopsy for amyloid detection and staging are considered. The detection of amyloid in tissue sections, which is considered to be the initial and the most critical step in the management of patients with amyloidosis, is entirely dependent upon the skill of the pathologist. Hence, there is an urgent need to increase the level of expertise applied in the diagnosis of amyloidosis among surgical pathologists and a need to concentrate on early detection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Picken MM, Westermark P. Amyloid detection and typing: summary of current practice and recommendations of the consensus group. Amyloid. 2011;18 Suppl 1:48–50.

    Article  PubMed  Google Scholar 

  2. Picken MM, Hazenberg BPC, Westermark P. Early detection of amyloid and its reporting: where are we now and where are we heading? In: Hazenberg BPC, Bijzet J, editors. The Proceedings of the XIIIth International Symposium on Amyloidosis; Netherlands: GUARD (Groningen Unit for Amyloidosis Research & Development) UMC Groningen; 2013. p. 459–465.

    Google Scholar 

  3. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21(4):221–4. Epub 2014 Sep 29.

    Article  PubMed  Google Scholar 

  4. Picken MM. Current practice in amyloid detection and typing among renal pathologists. Amyloid. 2011;18 Suppl 1:73–5.

    Article  PubMed  Google Scholar 

  5. Howie AJ, Brewer DB, Howell D, Jones AP. Physical basis of colors seen in Congo red-stained amyloid in polarized light. Lab Invest. 2008;88:232–42.

    Article  CAS  PubMed  Google Scholar 

  6. Howie AJ, Owen-Casey MP. Discrepancies between descriptions and illustrations of colours in Congo red-stained amyloid, and explanation of discrepant colours. Amyloid. 2010;17(3–4):109–17. Epub 2010 Nov 2.

    Article  PubMed  Google Scholar 

  7. Howie AJ, Owen-Casey MP. ‘Apple-green birefringence’ of amyloid stained by Congo red. Letter to the editor. Kid Int. 2012;82:114.

    Article  Google Scholar 

  8. Picken MM. Modern approaches to the treatment of amyloidosis—the critical importance of early detection in surgical pathology. Adv Anat Pathol. 2013;20(6):424–39.

    Article  CAS  PubMed  Google Scholar 

  9. Picken MM. Amyloidosis—where are we now and where are we heading? Arch Pathol Lab Med. 2010;134:545–51.

    PubMed  Google Scholar 

  10. Della Speranza V. Histologic preparations: common problems and their solutions College of American Pathologists; 2009. p. 133–137. http://www.cap.org/apps/docs/cap_press/Amyloid.pdf

  11. Rostagno A, Lashley T, Ng D, Meyerson J, Braendgaard H, Plant G, Bojsen-Møller M, Holton J, Frangione B, Revesz T, Ghiso J. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer’s disease. J Neurol Sci. 2007;257(1–2):88–96.

    Article  CAS  PubMed  Google Scholar 

  12. Rahimi F, Shanmugam A, Bitan G. Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer’s disease and related disorders. Curr Alzheimer Res. 2008;5(3):319–41.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Guerreiro N, Staufenbiel M, Gomez-Mancilla B. Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypes. J Alzheimers Dis. 2008;13(1):17–30.

    CAS  PubMed  Google Scholar 

  14. Tomidokoro Y, Rostagno A, Neubert TA, Lu Y, Rebeck GW, Frangione B, Greenberg SM, Ghiso J. Iowa variant of familial Alzheimer’s disease: accumulation of posttranslationally modified AβD23N in parenchymal and cerebrovascular amyloid deposits. Am J Pathol. 2010;176(4):1841–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol. 2001;159(6):1993–2000.

    Article  CAS  PubMed  Google Scholar 

  16. Santos SD, Fernandes R, Saraiva MJ. The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiol Aging. 2010;31(2):280–9.

    Article  CAS  PubMed  Google Scholar 

  17. Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Pattison JS, Robbins J. Protein misfolding and cardiac disease: establishing cause and effect. Autophagy. 2008;4(6):821–3.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci USA. 2010;107(9):4188–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804(7):1405–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Gallo G, Picken M, Frangione B, Buxbaum J. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component. Mod Pathol. 1988;1(6):453–6.

    CAS  PubMed  Google Scholar 

  22. Picken MM. Immunoglobulin Light and Heavy chain amyloid: renal pathology and differential diagnosis. Contrib Nephrol. 2007;153:135.

    Article  CAS  PubMed  Google Scholar 

  23. Picken MM, Frangione B, Barlogie B, Luna M, Gallo G. Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization. Am J Pathol. 1989;134(4):749–54.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Kapur U, Barton K, Fresco R, Leehey D, Picken MM. Expanding the pathologic spectrum of immunoglobulin Light Chain Proximal Tubulopathy. Arch Pathol Lab Med. 2007;131:1368.

    CAS  PubMed  Google Scholar 

  25. D’Souza A, Theis JD, Vrana JA, Dogan A. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid. 2014;21(2):71–5. Epub 2014 Jan 22.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Nilsson KP, et al. Conjugated polyelectrolytes–conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem. 2006;7(7):1096–104.

    Article  CAS  PubMed  Google Scholar 

  27. Nilsson KP, Ikenberg K, Aslund A, Fransson S, Konradsson P, Röcken C, Moch H, Aguzzi A. Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. Am J Pathol. 2010;176(2):563–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Magnusson K, Simon R, Sjölander D, Sigurdson CJ, Hammarström P, Nilsson KP. Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion. 2014;8(4):319–29. Epub 2014 Nov 1.

    Article  CAS  PubMed  Google Scholar 

  29. Sjöqvist J, Maria J, Simon RA, Linares M, Norman P, Nilsson KP, Lindgren M. Toward a molecular understanding of the detection of amyloid proteins with flexible conjugated oligothiophenes. J Phys Chem A. 2014;118(42):9820–7. Epub 2014 Oct 8.

    Article  PubMed  Google Scholar 

  30. Picken MM. Diagnosis of amyloid in urine cytology specimens. In: Hazenberg BPC, Bijzetthe J, editors. Proceedings of the XIIIth International Symposium on Amyloidosis; 2012 May 6–10; Groningen, Netherlands: GUARD; 2013. p. 161–2.

    Google Scholar 

  31. Klooster P, Bijzet J, Hazenberg BPC. Amyloid arthropathy in a patient with ATTR-Val122Ile amyloidosis. In: Hazenberg BPC, Bijzet J, editors. The Proceedings of the XIIIth International Symposium on Amyloidosis; Netherlands: GUARD (Groningen Unit for Amyloidosis Research & Development), UMC Groningen; 2013. p. 344–7.

    Google Scholar 

  32. Toll AD, Ali SZ. Urinary cytopathology in primary bladder amyloidosis. Acta Cytol. 2013;57(3):271–5. Epub 2013 Apr 25.

    Article  PubMed  Google Scholar 

  33. Ramirez-Alvarado M, Ward CJ, Huang BQ, Gong X, Hogan MC, Madden BJ, Charlesworth MC, Leung N. Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al). PLoS ONE. 2012;7(6):e38061. Epub 2012 Jun 18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria M. Picken MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Picken, M.M. (2015). Generic Diagnosis of Amyloid: A Summary of Current Recommendations and the Editor’s Comments on Chapters 13–16. In: Picken, M., Herrera, G., Dogan, A. (eds) Amyloid and Related Disorders. Current Clinical Pathology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-19294-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19294-9_17

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-19293-2

  • Online ISBN: 978-3-319-19294-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics